Privacy Policy – Medicine to Market

Stay up to date on the latest news

By pressing the Subscribe button, you confirm that you have read our Privacy Policy.

Biotech Industry Faces Policy Storm as Mid-2025 Market Pressures Intensify

Biotech Industry Faces Policy Storm as Mid-2025 Market Pressures Intensify

Summit Therapeutics’ Ivonescimab Shows Promise in Phase III Lung Cancer Trial Despite Mixed Results

Summit Therapeutics’ Ivonescimab Shows Promise in Phase III Lung Cancer Trial Despite Mixed Results

Astellas Pharma's $130 Million Deal with Evopoint Biosciences: A Major Step in Biotech Collaboration

Astellas Pharma’s $130 Million Deal with Evopoint Biosciences: A Major Step in Biotech Collaboration

Email Us

info at arsenal-advisors.com

Headquarters

Cambridge, MA USA